BPC-157 Oral

Also known as: BPC-157 Arginine Salt, BPC Stable

Acid-stable arginine salt form of BPC-157 for oral delivery; same VEGF/NO mechanism as injectable.

Typical dose: 250 mcg – 1 mg
Frequency: twice daily
Route: Oral
Half-life: 24 minutes
Routes: Oral
Status: Research chemical: not FDA approved

Track your BPC-157 Oral protocol in Vial →

Benefits

Gut healing (oral route)
Systemic anti-inflammatory
No injection required
Gastric ulcer repair

Dosing

A common research range for BPC-157 Oral is 250 mcg to 1 mg twice daily. Take on empty stomach. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Half-life

BPC-157 Oral has an approximate half-life of 24 minutes. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

Room temperature; desiccated.

Reported side effects

Nausea (rare)
GI discomfort

Contraindications

Active cancer (theoretical)

Commonly stacked with

TB-500

Track BPC-157 Oral with Vial

Vial logs every BPC-157 Oral dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. BPC-157 Oral is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.